-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Eiger BioPharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2020 to Q4 2023.
- Eiger BioPharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2023 was 1.48M shares, a 6.39% increase year-over-year.
- Eiger BioPharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 1.48M shares, a 6.39% increase from 2022.
- Eiger BioPharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 1.39M shares, a 95.9% decline from 2021.
- Eiger BioPharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 33.9M shares, a 20.6% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)